Pharmacodynamic material basis of licorice and mechanisms of modulating bile acid metabolism and gut microbiota in cisplatin-induced liver injury based on LC-MS and network pharmacology analysis
Journal of Ethnopharmacology · 2025-01 · 340 · 119293
DOI: 10.1016/j.jep.2024.119293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025-01. Verfasst von Jie Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science, Gansu University of Traditional Chinese Medicine, Lanzhou, 730000, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Chemical and Drug Induced Liver Injury, Cisplatin, Bile Acids and Salts. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Foundation for Innovative Research Groups of the National Natural Science Foundation of China, Chuzhou Science and Technology Program.
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Cisplatin (CP), a widely used antineoplastic agent, is a leading cause of drug-induced liver injury (DILI) due to its hepatotoxic effects. Licorice (GC), an established remedy in traditional Chinese medicine (TCM), has shown promise in addressing liver diseases and DILI. Nonetheless, the specific active components and underlying mechanisms of GC in mitigating CP-induced liver injury remain inadequately investigated. AIM OF THE STUDY: This study examined the active components and efficacy of GC in addressing CP-induced hepatotoxicity, focusing on its mechanisms related to bile acid metabolism and gut microbiota regulation. MATERIALS AND METHODS: Utilizing a CP-induced rat liver injury model, this study evaluated changes in liver coefficient, liver function indices, and pathological morphology while assessing the efficacy of GC for both prevention and treatment of CP-induced liver injury. Subsequently, UPLC-Q-TOF-MS qualitatively analyzed GC's blood-entering components, elucidating its pharmacodynamic material basis. Network pharmacology analysis identified potential pathways and targets of GC's blood components in relation to CP-induced liver injury. Furthermore, metabolomics and 16S rRNA sequencing were employed to clarify the pharmacodynamic mechanisms of GC in modulating bile acid metabolism and gut microbiota, offering insights into its preventive and therapeutic roles. RESULTS: The pharmacodynamic results revealed that GC significantly reduced liver function biomarkers and improved pathological changes in liver tissue. UPLC-Q-TOF-MS analysis identified 16 blood-entering components as potential pharmacodynamic agents of GC for preventing and treating CP-induced liver injury. Network pharmacology analysis suggested a link between GC's efficacy and the bile acid metabolic pathway. Furthermore, metabolomics analysis, immunoblotting, and 16S rRNA sequencing demonstrated that GC regulated bile acid metabolites in both liver and feces, enhanced FXR and BSEP expressions in the liver, and decreased CYP27A1 expression. Additionally, GC mitigated CP-induced intestinal dysbiosis by altering the abundance of gut microbiota. CONCLUSIONS: UPLC-Q-TOF-MS performed a qualitative analysis of 16 blood-entering components linked to GC, providing a basis for further exploration of the pharmacodynamic material underpinning GC. The protective role of GC in CP-induced liver injury appears connected to enhanced bile acid metabolism and restoration of gut microbiota balance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Science, Gansu University of Traditional Chinese Medicine, Lanzhou, 730000, China.
- Medical Faculty of Qinghai University, Xining, 810016, China.
- Shaanxi University of Chinese Medicine, Xi'an, 712046, China.
- School of Pharmaceutical Science, Gansu University of Traditional Chinese Medicine, Lanzhou, 730000, China. Electronic address: dengyi@gszy.edu.cn.
- School of Pharmaceutical Science, Gansu University of Traditional Chinese Medicine, Lanzhou, 730000, China. Electronic address: yangzhijun1971@yeah.net.
- School of Pharmaceutical Science, Gansu University of Traditional Chinese Medicine, Lanzhou, 730000, China. Electronic address: yangxiujuants@163.com.
Förderung
- National Natural Science Foundation of China
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
- Chuzhou Science and Technology Program
- Natural Science Foundation of Gansu Province
Zitieren
APA
Li, J., Lian, X., Li, B., Ma, Q., Yang, L., Gao, G., Yin, T., Fu, X., Deng, Y., Yang, Z., & Yang, X. (2025). Pharmacodynamic material basis of licorice and mechanisms of modulating bile acid metabolism and gut microbiota in cisplatin-induced liver injury based on LC-MS and network pharmacology analysis. Journal of Ethnopharmacology, 340, 119293. https://doi.org/10.1016/j.jep.2024.119293
Vancouver
Li J, Lian X, Li B, Ma Q, Yang L, Gao G, et al. Pharmacodynamic material basis of licorice and mechanisms of modulating bile acid metabolism and gut microbiota in cisplatin-induced liver injury based on LC-MS and network pharmacology analysis. Journal of Ethnopharmacology. 2025;340:119293. doi:10.1016/j.jep.2024.119293
BibTeX
@article{Li2025,
author = {Li, Jie and Lian, Xiaolong and Li, Baojian and Ma, Quhuan and Yang, Lingling and Gao, Guangmiao and Yin, Tingmei and Fu, Xiaoyan and Deng, Yi and Yang, Zhijun and Yang, Xiujuan},
title = {Pharmacodynamic material basis of licorice and mechanisms of modulating bile acid metabolism and gut microbiota in cisplatin-induced liver injury based on LC-MS and network pharmacology analysis},
journal = {Journal of Ethnopharmacology},
year = {2025},
volume = {340},
pages = {119293},
doi = {10.1016/j.jep.2024.119293}
}
EUVIMED